OPKO Health, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
OPKO Health, Inc. (OPK) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2017-12-31, per its 8-K filed 2019-01-29.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2019-01-29
- OPKO Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2016-12-31 was $0.00.
- OPKO Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2016-09-30 was $0.00.
- OPKO Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2016-06-30 was $0.00.
- OPKO Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2016-03-31 was $0.00.
- OPKO Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2014 was -$2.97M.
- OPKO Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2013 was -$2.94M.
- OPKO Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2012 was -$492.00K.
- OPKO Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2011 was $0.00.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 8-K · filed 2019-01-29 | ||||
| 2016-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $0.00 derived: sum of 2 quarters · filed 2019-01-29 | $0.00 derived: sum of 3 quarters · filed 2019-01-29 | $0.00 8-K · filed 2019-01-29 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | $0.00 derived: sum of 4 quarters · filed 2019-01-29 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-01-29 | $0.00 derived: sum of 4 quarters · filed 2019-01-29 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-01-29 | $0.00 derived: sum of 3 quarters · filed 2019-01-29 | -$475.00K derived: sum of 4 quarters · filed 2019-01-29 | |
| 2015-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $0.00 derived: sum of 2 quarters · filed 2019-01-29 | -$475.00K derived: sum of 3 quarters · filed 2019-01-29 | -$1.40M 8-K · filed 2019-01-29 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-07 | -$475.00K derived: sum of 2 quarters · filed 2016-11-07 | -$1.40M 10-Q · filed 2016-11-07 | -$1.89M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | -$475.00K 10-Q · filed 2016-08-08 | -$1.40M 10-Q · filed 2016-08-08 | -$1.89M derived: sum of 3 quarters · filed 2017-03-01 | -$3.24M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | -$925.00K 10-Q · filed 2016-05-09 | -$1.42M derived: sum of 2 quarters · filed 2017-03-01 | -$2.76M derived: sum of 3 quarters · filed 2017-03-01 | -$3.36M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$491.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$1.84M derived: sum of 2 quarters · filed 2017-03-01 | -$2.43M derived: sum of 3 quarters · filed 2017-03-01 | -$2.97M 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$1.34M 10-Q · filed 2015-11-09 | -$1.94M derived: sum of 2 quarters · filed 2015-11-09 | -$2.48M 10-Q · filed 2015-11-09 | -$3.11M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$597.00K 10-Q · filed 2015-08-05 | -$1.14M 10-Q · filed 2015-08-05 | -$1.77M derived: sum of 3 quarters · filed 2016-02-29 | -$2.57M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$540.00K 10-Q · filed 2015-05-11 | -$1.17M derived: sum of 2 quarters · filed 2016-02-29 | -$1.97M derived: sum of 3 quarters · filed 2016-02-29 | -$2.93M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$630.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$1.43M derived: sum of 2 quarters · filed 2016-02-29 | -$2.39M derived: sum of 3 quarters · filed 2016-02-29 | -$2.94M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$803.00K 10-Q · filed 2014-11-07 | -$1.76M derived: sum of 2 quarters · filed 2014-11-07 | -$2.31M 10-Q · filed 2014-11-07 | -$2.80M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-06-30 | -$959.00K 10-Q · filed 2014-08-11 | -$1.51M 10-Q · filed 2014-08-11 | -$2.00M derived: sum of 3 quarters · filed 2015-02-27 | -$2.00M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | -$547.00K 10-Q · filed 2014-05-09 | -$1.04M derived: sum of 2 quarters · filed 2015-02-27 | -$1.04M derived: sum of 3 quarters · filed 2015-02-27 | -$1.04M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | -$492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$492.00K derived: sum of 2 quarters · filed 2015-02-27 | -$492.00K derived: sum of 3 quarters · filed 2015-02-27 | -$492.00K 10-K · filed 2015-02-27 | $492.00K 10-K · filed 2013-03-18 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |